In a recent study of Andreassen et al., the tumors of 80 patients showed less staining for insulin and proinsulin in malignant insulinoma cases vs. benign lesions, possibly due to a diminished insulin storage capacity; to the contrary, glucagon staining was present only in malignant tumors. This evidence concerns the gene INS and pancreatic insulinoma.